No Data
No Data
GMO Broadcasting is enhancing support for high school students' programming education and educational DX in collaboration with paiza.
GMO Media <6180> announced on the 11th that it will enhance its support for high school programming education and teacher administration DX in collaboration with paiza. GMO Media has created a small test creation tool called 'Koeteko Study by GMO' for the purpose of supporting high school DX, while paiza provides an online programming learning service called 'paiza Learning School Free Pass', which allows students to learn through videos and problem solving and is directly linked to employment and career change. Through this collaboration, initially 20...
GMO Media: Q2 Financial Results Q&A Collection for the Fiscal Year Ending December 2024 (2)
GMO broadcasting---Providing a "Brain Training Gaming supervised by Dr. Ryuta Kawashima" that can be expected to prevent dementia, in the "Easy Gaming Box by GMO"
On August 27, 2024, GMO Media<6180> announced that they have started offering a new content, 'Brain Training Games', supervised by Dr. Ryuta Kawashima, on their casual gaming platform 'Easy Game Box by GMO'. 'Easy Game Box by GMO' is a platform that provides free casual browser games that can be played on PCs and smartphones, including puzzles, quizzes, and brain training.
GMO Broadcasting---Acquired 552 shares (voting rights 75.1%) of Shuminavi's stock and made it a subsidiary.
GMO Media <6180> announced on the 20th that it will acquire 552 shares (75.1% voting rights) of Shuminavi's stock and make it a subsidiary. The company provides "Koeteko College by GMO", where anyone can easily start online courses. Shuminavi operates a platform for hobbies and learning, facilitating matching between "participants" and "organizers". By becoming a subsidiary of the same company this time, it will expand its business skills, arts, fitness, etc.
Light Up, Stella Pharma, and others.
<4258> NTT Communications, which handles the ICT service and solutions business, etc., has signed a sales agency agreement with dealers. <4596> Kubota Pharmaceutical HD's 33rd new share subscription rights (with a exercise price modification clause issued (14 million potential shares, procurement amount of approximately 0.972 billion yen) <4888> Stella Pharma Borofaran (10B) (SPM-011) applies for orphan drug designation for recurrent malignant gliomas and recurrent meningomas. <5129> FIXER downward revision.
GMO Media: Question-and-answer collection for the second quarter of the fiscal year ending December 2024.
No Data
No Data